0001437749-21-013593.txt : 20210527 0001437749-21-013593.hdr.sgml : 20210527 20210527205108 ACCESSION NUMBER: 0001437749-21-013593 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210525 FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATHIESEN JEFFREY S CENTRAL INDEX KEY: 0001296853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39468 FILM NUMBER: 21975455 MAIL ADDRESS: STREET 1: 43334 SEVEN MILE RD. STREET 2: SUITE 1000 CITY: NORTHVILLE STATE: MI ZIP: 48167 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Panbela Therapeutics, Inc. CENTRAL INDEX KEY: 0001029125 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870543922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 BUSINESS PHONE: 9524791196 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 FORMER COMPANY: FORMER CONFORMED NAME: Sun BioPharma, Inc. DATE OF NAME CHANGE: 20150911 FORMER COMPANY: FORMER CONFORMED NAME: Cimarron Medical, Inc. DATE OF NAME CHANGE: 20150602 FORMER COMPANY: FORMER CONFORMED NAME: CIMARRON SOFTWARE INC DATE OF NAME CHANGE: 19961217 4 1 rdgdoc.xml FORM 4 X0306 4 2021-05-25 0001029125 Panbela Therapeutics, Inc. PBLA 0001296853 MATHIESEN JEFFREY S 712 VISTA BLVD #305 WACONIA MN 55387 1 Common Stock 2021-05-25 4 A 0 4316 0 A 10191 D Stock Option (right to buy) 4.17 2021-05-25 4 A 0 12368 0 A 2031-05-25 Common Stock 12368 12368 D Scheduled to vest and become exercisable in four equal increments on August 25, 2021, November 24, 2021, February 25, 2022 and the earlier of May 31, 2022 and the day before the company's annual meeting of stockholders to be held in 2022. /s/ Joshua L. Colburn, Attorney-in-Fact 2021-05-27